These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35181492)

  • 21. Lipoamino bundle LNPs for efficient mRNA transfection of dendritic cells and macrophages show high spleen selectivity.
    Haase F; Pöhmerer J; Yazdi M; Grau M; Zeyn Y; Wilk U; Burghardt T; Höhn M; Hieber C; Bros M; Wagner E; Berger S
    Eur J Pharm Biopharm; 2024 Jan; 194():95-109. PubMed ID: 38065313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biodistribution and Non-linear Gene Expression of mRNA LNPs Affected by Delivery Route and Particle Size.
    Di J; Du Z; Wu K; Jin S; Wang X; Li T; Xu Y
    Pharm Res; 2022 Jan; 39(1):105-114. PubMed ID: 35080707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Arrayed CRISPR Screening Identifies Novel Targets That Enhance the Productive Delivery of mRNA by MC3-Based Lipid Nanoparticles.
    Ross-Thriepland D; Bornot A; Butler L; Desai A; Jaiswal H; Peel S; Hunter MR; Odunze U; Isherwood B; Gianni D
    SLAS Discov; 2020 Jul; 25(6):605-617. PubMed ID: 32441189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles.
    Nakamura T; Nakade T; Sato Y; Harashima H
    Int J Pharm; 2023 Apr; 636():122810. PubMed ID: 36898618
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In situ T-cell transfection by anti-CD3-conjugated lipid nanoparticles leads to T-cell activation, migration, and phenotypic shift.
    Kheirolomoom A; Kare AJ; Ingham ES; Paulmurugan R; Robinson ER; Baikoghli M; Inayathullah M; Seo JW; Wang J; Fite BZ; Wu B; Tumbale SK; Raie MN; Cheng RH; Nichols L; Borowsky AD; Ferrara KW
    Biomaterials; 2022 Feb; 281():121339. PubMed ID: 35078042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mechanical properties of lipid nanoparticles depend on the type of biomacromolecule they are loaded with.
    de Chateauneuf-Randon S; Bresson B; Ripoll M; Huille S; Barthel E; Monteux C
    Nanoscale; 2024 Jun; 16(22):10706-10714. PubMed ID: 38700424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Size-controlled lipid nanoparticle production using turbulent mixing to enhance oral DNA delivery.
    He Z; Hu Y; Nie T; Tang H; Zhu J; Chen K; Liu L; Leong KW; Chen Y; Mao HQ
    Acta Biomater; 2018 Nov; 81():195-207. PubMed ID: 30267888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation.
    Kim J; Jozic A; Lin Y; Eygeris Y; Bloom E; Tan X; Acosta C; MacDonald KD; Welsher KD; Sahay G
    ACS Nano; 2022 Sep; 16(9):14792-14806. PubMed ID: 36038136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Biomolecular Corona of Lipid Nanoparticles for Gene Therapy.
    Francia V; Schiffelers RM; Cullis PR; Witzigmann D
    Bioconjug Chem; 2020 Sep; 31(9):2046-2059. PubMed ID: 32786370
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid nanoparticles for delivery of messenger RNA to the back of the eye.
    Patel S; Ryals RC; Weller KK; Pennesi ME; Sahay G
    J Control Release; 2019 Jun; 303():91-100. PubMed ID: 30986436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform.
    Bailey-Hytholt CM; Ghosh P; Dugas J; Zarraga IE; Bandekar A
    J Vis Exp; 2021 Feb; (168):. PubMed ID: 33720139
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Taylor Dispersion Analysis to support lipid-nanoparticle formulations for mRNA vaccines.
    Malburet C; Leclercq L; Cotte JF; Thiebaud J; Bazin E; Garinot M; Cottet H
    Gene Ther; 2023 May; 30(5):421-428. PubMed ID: 36316446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nanoparticle single-cell multiomic readouts reveal that cell heterogeneity influences lipid nanoparticle-mediated messenger RNA delivery.
    Dobrowolski C; Paunovska K; Schrader Echeverri E; Loughrey D; Da Silva Sanchez AJ; Ni H; Hatit MZC; Lokugamage MP; Kuzminich Y; Peck HE; Santangelo PJ; Dahlman JE
    Nat Nanotechnol; 2022 Aug; 17(8):871-879. PubMed ID: 35768613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell mimetic liposomal nanocarriers for tailored delivery of vascular therapeutics.
    Mattern-Schain SI; Fisher RK; West PC; Grimsley LB; Harris TM; Grandas OH; Best MD; Mountain DJH
    Chem Phys Lipids; 2019 Jan; 218():149-157. PubMed ID: 30582896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nucleic Acid-Loaded Lipid Nanoparticle Interactions with Model Endosomal Membranes.
    Spadea A; Jackman M; Cui L; Pereira S; Lawrence MJ; Campbell RA; Ashford M
    ACS Appl Mater Interfaces; 2022 Jul; 14(26):30371-30384. PubMed ID: 35758331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipid-nucleic acid nanoparticles of novel ionizable lipids for systemic BMP-9 gene delivery to bone-marrow mesenchymal stem cells for osteoinduction.
    Vhora I; Lalani R; Bhatt P; Patil S; Misra A
    Int J Pharm; 2019 May; 563():324-336. PubMed ID: 30954673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment.
    Xue L; Gong N; Shepherd SJ; Xiong X; Liao X; Han X; Zhao G; Song C; Huang X; Zhang H; Padilla MS; Qin J; Shi Y; Alameh MG; Pochan DJ; Wang K; Long F; Weissman D; Mitchell MJ
    J Am Chem Soc; 2022 Jun; 144(22):9926-9937. PubMed ID: 35616998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kinetics of RNA-LNP delivery and protein expression.
    Müller JA; Schäffler N; Kellerer T; Schwake G; Ligon TS; Rädler JO
    Eur J Pharm Biopharm; 2024 Apr; 197():114222. PubMed ID: 38387850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rational design of anti-inflammatory lipid nanoparticles for mRNA delivery.
    Zhang H; Han X; Alameh MG; Shepherd SJ; Padilla MS; Xue L; Butowska K; Weissman D; Mitchell MJ
    J Biomed Mater Res A; 2022 May; 110(5):1101-1108. PubMed ID: 35076171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery.
    Swingle KL; Billingsley MM; Bose SK; White B; Palanki R; Dave A; Patel SK; Gong N; Hamilton AG; Alameh MG; Weissman D; Peranteau WH; Mitchell MJ
    J Control Release; 2022 Jan; 341():616-633. PubMed ID: 34742747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.